Other substances

1,2,3-triazole-phtalimide compound E40

A 1,2,3-triazole-phthalimide derivative.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

1,2,3-triazole-phtalimide compound E40 was computationally predicted to bind SARS-CoV-2 3C-like protease and Nucleocapside protein (Holanda et al., 2021).

 

Structure image - 1,2,3-triazole-phtalimide compound E40

CC(N1C(=O)C2=C(C=C(C)C=C2)C1=O)C1=NC2=CC=CC=C2N1CC1=CN(N=N1)C1=CC=NC=C1

Supporting references

Link Tested on Impact factor Notes Publication date
Identification of 1,2,3-triazole-phthalimide derivatives as potential drugs against COVID-19: a virtual screening, docking and molecular dynamic study
3CLpro Nucleocapsid protein Small molecule In silico 		in silico 3.22

Predicted to bind SARS-CoV-2 3C-like protease and Nucleocapsid protein.

 Jan/18/2021
Export (.csv)